Device Trial Radar · NCT01879696
Double Blinded, Randomized Clinical Trial of the Twin Star ECSPRESS Monitoring System for the Reduction of the Incidence of Fasciotomy
Last checked: Nov 19, 2026Latest source record: Jun 18, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Jun 2013
Primary completion
May 2014
Study completion Jun 2015
Sponsor
- Lead sponsor
- Twin Star Medical, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- United States Department of Defense
- First posted
- Jun 18, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 44 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The proposed study is a double-blinded, randomized clinical trial of tissue pressure monitoring only (Control group) vs. tissue pressure monitoring plus tissue ultrafiltration (Treatment group) in patients with tibia fractures presenting to the trauma or emergency departments at participating clinical sites. Tissue ultrafiltration refers to the removal of muscle interstitial fluid by the ECSPRESS PMFC. The primary objective of the study is to demonstrate whether the removal of interstitial fluid by the ECSPRESS PMFC/FC catheters decrease the incidence of fasciotomy in the Treatment group when compared to the Control group. Fasciotomy was chosen as the primary outcome because it is clearly defined and clinically relevant; reduction of fasciotomy is of clear clinical benefit. Enrolled patients may have isolated tibia fractures OR be multiple trauma patients (those with another major fracture in a different body region or two distinct body system injuries, excluding those with injuries to the opposite leg that would preclude them from completing required tests).
Conditions
- Compartment Syndrome
Interventions
ECSPRESS catheter with active vacuumDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of fasciotomiesTime frame: End of study once all subjects have completed their 12 month follow-up interval.
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Missouri-Columbia
Columbia, Missouri
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.